BSX Boston Scientific Corp

$95.84

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/2/2025

About Boston Scientific Corp

Boston Scientific Corporation, doing business as Boston Scientific, is a manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Website: https://www.bostonscientific.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
885725
Address
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, US
Valuation
Market Cap
$140.69B
P/E Ratio
76.10
PEG Ratio
1.87
Price to Book
6.46
Performance
EPS
$1.25
Dividend Yield
—
Profit Margin
11.10%
ROE
8.89%
Technicals
50D MA
$100.16
200D MA
$89.39
52W High
$107.17
52W Low
$66.80
Fundamentals
Shares Outstanding
1B
Target Price
$114.94
Beta
0.73

BSX EPS Estimates vs Actual

● Estimated
● Actual

BSX News & Sentiment

Oct 01, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Boston Scientific ( BSX ) Stock Dips While Market Gains: Key Facts
The latest trading day saw Boston Scientific (BSX) settling at $95.85, representing a -1.82% change from its previous close.
Oct 01, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum
HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.
Oct 01, 2025 • Benzinga SOMEWHAT-BULLISH
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million - Boston Scientific ( NYSE:BSX ) , Elutia ( NASDAQ:ELUT )
- Strengthened balance sheet to fully fund development and launch of NXT-41 platform - - Biologics for breast reconstruction represents $1.5 billion U.S. total addressable market -
Oct 01, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million
- Strengthened balance sheet to fully fund development and launch of NXT-41 platform ...
Oct 01, 2025 • Benzinga SOMEWHAT-BULLISH
Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday - Boston Scientific ( NYSE:BSX ) , Banc of California ( NYSE:BANC )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Telsey Advisory Group raised Victoria's Secret & Co ( NYSE:VSCO ) price target from $24 to $29.
Oct 01, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Unlocking Cures: How AI is Reshaping Cancer Research & Healthcare ETFs?
AI's growing role in cancer research, and a new federal push for pediatric oncology, are powering gains in key healthcare ETFs.
Sentiment Snapshot

Average Sentiment Score:

0.227
50 articles with scored sentiment

Overall Sentiment:

Bullish

BSX Reported Earnings

Apr 22, 2025
Mar 31, 2025 (Pre market)
0.08 Surprise
  • Reported EPS: $0.75
  • Estimate: $0.67
  • Whisper: —
  • Surprise %: 11.5%
Jan 29, 2025
Dec 31, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.70
  • Estimate: $0.66
  • Whisper: —
  • Surprise %: 6.6%
Oct 23, 2024
Sep 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.63
  • Estimate: $0.59
  • Whisper: —
  • Surprise %: 6.8%
Jul 24, 2024
Jun 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.62
  • Estimate: $0.58
  • Whisper: —
  • Surprise %: 6.9%
Apr 24, 2024
Mar 31, 2024 (Pre market)
0.05 Surprise
  • Reported EPS: $0.56
  • Estimate: $0.51
  • Whisper: —
  • Surprise %: 9.8%
Jan 31, 2024
Dec 31, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $0.55
  • Estimate: $0.51
  • Whisper: —
  • Surprise %: 7.8%
Oct 26, 2023
Sep 30, 2023 (Pre market)
0.02 Surprise
  • Reported EPS: $0.50
  • Estimate: $0.48
  • Whisper: —
  • Surprise %: 4.2%
Jul 27, 2023
Jun 30, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $0.53
  • Estimate: $0.49
  • Whisper: —
  • Surprise %: 8.2%
Apr 26, 2023
Mar 31, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $0.47
  • Estimate: $0.44
  • Whisper: —
  • Surprise %: 6.8%

Financials